Elicio Therapeutics, Inc. (ELTX) vs ImageneBio, Inc. (IMA)

Elicio Therapeutics, Inc. and ImageneBio, Inc. are both Biotechnology companies. Elicio Therapeutics, Inc. and ImageneBio, Inc. are of similar size ($53.4M and $52.9M). Elicio Therapeutics, Inc. grew revenue faster over the last twelve months: 921.0% against −68.0%. Across the 14 metrics below, ImageneBio, Inc. leads on 8 and Elicio Therapeutics, Inc. on 6.

Valuation

Metric ELTX IMA Biotechnology median
P/E n/m n/m 7.88
P/S 1.23 12.42 11.47
P/B 4.46 0.54 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 0.78 4.31 10.73
Earnings yield (117.93%) (110.51%) (28.84%)
Free cash flow yield (106.74%) (67.66%) (23.03%)

Profitability

Metric ELTX IMA Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (774.56%) (41.34%) (57.72%)
Return on assets (124.36%) (38.34%) (49.22%)
Return on invested capital 0.00% (622.37%) 0.00%

Growth

Metric ELTX IMA Biotechnology median
Revenue growth (TTM) 921.02% (67.95%) 5.64%
EPS growth (last fiscal year) 39.29% 21.27% —
Revenue growth, 5-year CAGR — (38.64%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELTX IMA Biotechnology median
Debt to equity 1.20 0.00 0.00
Current ratio 2.77 21.47 4.73
Net debt to EBITDA 0.25 2.85 0.96

Dividend

Metric ELTX IMA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ELTX IMA Biotechnology median
Market cap 53.35m 52.90m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack